Search clinical trials for: MOC31PE Immunotoxin
Total 238 results
-
Oslo University HospitalCompleted
-
Cambridge Antibody TechnologyUnknownLeukemia | Hairy Cell Leukemia | HCLUnited States, Poland, United Kingdom
-
Cambridge Antibody TechnologyUnknownLeukemiaUnited States, Poland
-
National Cancer Institute (NCI)Completed
-
Duke UniversityNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...UnknownAcute Lymphoblastic LeukemiaItaly
-
National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
MedImmune LLCCompletedLymphoma | LeukemiaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRecurrent Glioblastoma Multiforme
-
National Cancer Institute (NCI)WithdrawnLymphoma | LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedCervical Cancer | Head and Neck Cancer | Pancreatic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Lung Cancer | Malignant Mesothelioma | Primary Peritoneal Cavity CancerUnited States
-
Cambridge Antibody TechnologyUnknownLeukemia | Non-Hodgkin's Lymphoma | NHLUnited States, Poland
-
University of Maryland, BaltimoreNational Cancer Institute (NCI)CompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Bladder CancerUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedCervical Cancer | Head and Neck Cancer | Pancreatic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Lung Cancer | Malignant Mesothelioma | Primary Peritoneal Cavity CancerUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)TerminatedBrain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Bladder CancerUnited States
-
INSYS Therapeutics IncWithdrawn
-
M.D. Anderson Cancer CenterMedImmune LLCTerminated
-
University Hospital FreiburgNational Cancer Institute (NCI)UnknownGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal CancerGermany
-
MedImmune LLCCambridge Antibody TechnologySuspendedLymphoma | LeukemiaUnited States
-
National Cancer Institute (NCI)Completed
-
University of Texas Southwestern Medical CenterTerminated
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedMelanoma (Skin) | Non-melanomatous Skin CancerUnited States
-
Oslo University HospitalCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLymphoma | Lymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Leukemia | Leukemia, Myeloid | Hodgkin Disease | Leukemia, Myelomonocytic, Chronic | Graft vs Host Disease | Leukemia, Lymphocytic | Lymphoma, Mantle-cellUnited States
-
National Cancer Institute (NCI)CompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent OsteosarcomaUnited States, Canada, Puerto Rico
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...WithdrawnCHRONIC LYMPHOCYTIC B-LEUKEMIA
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)Completed
-
MedImmune LLCTerminatedLymphomaUnited States, Poland
-
MedImmune LLCNational Cancer Institute (NCI)CompletedNon-Hodgkin's Lymphoma | Acute Lymphoblastic LeukemiaUnited States, Canada
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Withdrawn
-
MedImmune LLCTerminatedB-Cell Pediatric ALLUnited States, Australia, France, Spain, Canada, Netherlands, United Kingdom, Italy
-
University of WashingtonNational Cancer Institute (NCI)CompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma and other conditionsUnited States
-
AstraZenecaApproved for marketingRelapsed/Refractory Hairy Cell Leukemia
-
MedImmune LLCCambridge Antibody TechnologyCompletedHairy Cell LeukemiaUnited States, Poland
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Center for International Blood and Marrow Transplant...MedImmune LLC; National Marrow Donor Program; Pediatric Blood and Marrow Transplant... and other collaboratorsTerminatedAcute Lymphoblastic Leukemia (ALL)United States
-
MedImmune LLCCambridge Antibody TechnologyTerminatedLeukemia, Lymphoma, Chronic Lymphocytic | Leukemia, Prolymphocytic Leukemia, Small | Lymphocytic Lymphoma, Moxetumomab PasudotoxUnited States, Poland
-
Imagine InstituteTakedaCompletedEnteropathy Associated T-cell LymphomaFrance
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
MedImmune LLCCompletedLeukemia, Hairy CellItaly, Spain, United States, Belgium, Poland, Czechia, Germany, Serbia, United Kingdom, France, Israel, Ireland, Canada, Norway
-
Deepa JagadeeshRecruitingAngioimmunoblastic T-cell Lymphoma | T-cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Enteropathy Associated T-cell Lymphoma | Hepato-splenic T-cell Lymphoma | NK T-cell LymphomaUnited States
-
TakedaRecruitingHodgkin LymphomaJapan
-
National Cancer Institute (NCI)WithdrawnMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditions
-
Duke UniversityNational Institutes of Health (NIH)CompletedBacteremiaUnited States, Spain
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Ovarian Germ Cell TumorUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.RecruitingMycosis Fungoides | Sezary Syndrome | Lymphomatoid PapulosisUnited States